Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW. Sieuwerts AM, et al. Among authors: foekens ja. Clin Cancer Res. 2011 Jun 1;17(11):3600-18. doi: 10.1158/1078-0432.CCR-11-0255. Epub 2011 Apr 19. Clin Cancer Res. 2011. PMID: 21505063
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.
Martens JW, Nimmrich I, Koenig T, Look MP, Harbeck N, Model F, Kluth A, Bolt-de Vries J, Sieuwerts AM, Portengen H, Meijer-Van Gelder ME, Piepenbrock C, Olek A, Höfler H, Kiechle M, Klijn JG, Schmitt M, Maier S, Foekens JA. Martens JW, et al. Among authors: foekens ja. Cancer Res. 2005 May 15;65(10):4101-17. doi: 10.1158/0008-5472.CAN-05-0064. Cancer Res. 2005. PMID: 15899800
How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, Portengen H, Klijn JG, Foekens JA. Sieuwerts AM, et al. Among authors: foekens ja. Clin Cancer Res. 2005 Oct 15;11(20):7311-21. doi: 10.1158/1078-0432.CCR-05-0560. Clin Cancer Res. 2005. PMID: 16243802
Genes associated with breast cancer metastatic to bone.
Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, Martens JW, Foekens JA. Smid M, et al. Among authors: foekens ja. J Clin Oncol. 2006 May 20;24(15):2261-7. doi: 10.1200/JCO.2005.03.8802. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636340
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
Sieuwerts AM, Look MP, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, de Weerd V, Portengen H, Klijn JG, Foekens JA. Sieuwerts AM, et al. Among authors: foekens ja. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3319-28. doi: 10.1158/1078-0432.CCR-06-0225. Clin Cancer Res. 2006. PMID: 16740753
Subtypes of breast cancer show preferential site of relapse.
Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, Foekens JA, Martens JW. Smid M, et al. Among authors: foekens ja. Cancer Res. 2008 May 1;68(9):3108-14. doi: 10.1158/0008-5472.CAN-07-5644. Cancer Res. 2008. PMID: 18451135
Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer.
Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA. Van den Eynden GG, et al. Among authors: foekens ja. Clin Cancer Res. 2008 May 15;14(10):2944-52. doi: 10.1158/1078-0432.CCR-07-4397. Clin Cancer Res. 2008. PMID: 18483361
411 results